Kobo Biotech share news, announcements and annual reports
BSE: 531541Chemicals & PetrochemicalsSmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹3.87.
30 Oct: open ₹3.80, high ₹3.80, low ₹3.80
- Under BSE's graded surveillance, stage 0, on the list for 29 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹9.05 Cr4,799th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- No recent results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- No recent results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 5,152
Kobo Biotech share news and announcements
420 announcements, routine notices left out, newest first. Page 2 of 9.
May 2024
31 May · Stay On The NCLT Order Dated 15Th May, 2024 Of M/S. Arch Pharmalabs Limited ("Promoter Entity")
23 May · Board meeting
Meeting on 30 May 2024: audited results17 May · Admission Of Application Under Section 7 Of Insolvency And Bankruptcy Code, 2016 Against M/S. Arch Pharmalabs Limited ("Promoter Entity")
Apr 2024
26 Apr · Compliance Certificate Under Regulation 7(3)
Feb 2024
7 Feb · Board meeting
Meeting on 14 Feb 2024: quarterly results
Nov 2023
10 Nov · Related Party Transaction For The Hald Year Ended 30-09-2023
3 Nov · Board meeting
Meeting on 10 Nov 2023: quarterly results
Oct 2023
Sep 2023
30 Sep · Meeting
9 Sep · 30Th Annual Report For The Financial Year 2022-23
Aug 2023
3 Aug · Board meeting
Meeting on 11 Aug 2023: quarterly results
May 2023
30 May · Disclosure Of Related Party Transactions For The Half Year Ended 31St March, 2023
24 May · Board meeting
Meeting on 30 May 2023: audited results
Apr 2023
18 Apr · Certificate Pursuant To Regulation 40(9) Of SEBI (LODR) Regulations, 2015 For The Half Year Ended 31St March, 2023
18 Apr · Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations, 2015 For The Year Ended 31St March, 2023.
1 Apr · Meeting
Feb 2023
27 Feb · Meeting
6 Feb · Board meeting
Meeting on 13 Feb 2023: quarterly results
Nov 2022
29 Nov · Disclosure Of Related Party Transactions For The Half Year Ended 30Th September, 2022 Pursuant To Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
7 Nov · Board meeting
Meeting on 14 Nov 2022: quarterly results
Oct 2022
18 Oct · Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2022
17 Sep · Meeting
8 Sep · Reg. 34 (1) Annual Report.
Aug 2022
12 Aug · Announcement under Regulation 30 (LODR)-Change in Registered Office Address